The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Miriam Merad named dean for Translational Research and Therapeutic Innovation at Mt. Sinai

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Miriam Merad was named dean for Translational Research and Therapeutic Innovation of the Icahn School of Medicine at Mount Sinai. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

PodcastThe Directors

The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)
Cancer centers fund small grants to boost morale amid low paylines

As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.
By Paul Goldberg and Claire Marie Porter
Cancer Policy

Tens of thousands of healthcare workers strike across the country

Around 31,000 healthcare workers in California and Hawaii joined the picket line Jan. 26 as the United Nurses Associations of California/Union of Health Care  Professionals and Kaiser Permanente reached an impasse in contract negotiations.xxx:moreThis is while 15,000 nurses are in their third week of striking in New York City in what the New York State Nurses Association
By Sara Willa Ernst
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account